Senores Pharmaceuticals Ltd (SENORES) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039497, "name": "Senores Pharma.", "stock_name": "Senores Pharma.", "full_name": "Senores Pharmaceuticals Ltd", "name_url": "stocks-analysis/senores-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "820.20", "chg": 16.05, "chgp": "2.0%", "dir": 1, "prev_price": "804.15", "mcapval": "3,763.00 Cr", "mcap": "Small Cap", "scripcode": "544319", "symbol": "SENORES", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE0RB801010", "curr_date": "Apr 10", "curr_time": "", "bse_nse_vol": "2.36 lacs", "exc_status": "Active", "traded_date": "Apr 10, 2026", "traded_date_str": "2026 04 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Senores Pharmaceuticals Gains 5.88%: 3 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-gains-588-3-key-factors-driving-the-week-3942196", "imagepath": "", "date": "2026-04-11 09:03:51", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>6 Apr:</strong> Week opens at Rs.777.75</p>\n <p><strong>7 Apr:</strong> Technical momentum shifts amid mixed market signals</p>\n <p><strong>8 Apr:</strong> Stock rebounds with 1.59% gain following technical caution</p>\n <p><strong>9 Apr:</strong> Upgrade to Buy rating announced alongside technical improvement</p>\n <p><strong>10 Apr:</strong> Week closes at Rs.823.45, up 5.88% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.777.75</div></div>\n <div ..." }, { "title": "Senores Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Improvement", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-technical-improvement-3939053", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_mojoScore_3939053.png", "date": "2026-04-09 08:37:15", "description": "Senores Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The upgrade reflects the company’s robust quarterly performance, improving technical signals, and sustained market-beating returns, positioning it favourably within the Pharmaceuticals & Biotechnology sector." }, { "title": "Senores Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-3938899", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_technicaldot_3938899.png", "date": "2026-04-09 08:07:12", "description": "Senores Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and volume-based metrics, signalling a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "Senores Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3935624", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_technicaldot_3935624.png", "date": "2026-04-07 08:06:18", "description": "Senores Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance as of early April 2026. Despite a modest decline in its share price, the company’s technical indicators present a complex picture, reflecting both short-term caution and longer-term resilience within the Pharmaceuticals & Biotechnology sector." }, { "title": "Senores Pharmaceuticals’ Mixed Week: -0.33% Price Change Amid Technical and Valuation Shifts", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-mixed-week--033-price-change-amid-technical-and-valuation-shifts-3931644", "imagepath": "", "date": "2026-04-04 09:03:15", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>30 Mar:</strong> Upgrade to Buy on strong financials and technical shift</p>\n <p><strong>30 Mar:</strong> Technical momentum shifts to mildly bullish</p>\n <p><strong>1 Apr:</strong> Significant gap up opens trading (+5.28%)</p>\n <p><strong>2 Apr:</strong> Downgrade to Hold amid mixed technicals and valuation concerns</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.788.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.785.40<..." }, { "title": "Senores Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-downgraded-to-hold-amid-mixed-technicals-and-valuation-concerns-3929729", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_mojoScore_3929729.png", "date": "2026-04-02 08:38:19", "description": "Senores Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 1 April 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and market-beating returns, the company’s technical outlook and valuation metrics have prompted a more cautious stance from analysts." }, { "title": "Senores Pharmaceuticals Ltd Opens 5.28% Higher in Sharp Gap Up, But Can the Technicals Support It?", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-opens-strong-with-significant-gap-up-on-1-april-2026-3928183", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SenoresPharmace_gapup_3928183.png", "date": "2026-04-01 09:36:55", "description": "" }, { "title": "Senores Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Shift", "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharmaceuticals-upgraded-to-buy-on-strong-financials-and-technical-shift-3923548", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_mojoScore_3923548.png", "date": "2026-03-30 08:12:25", "description": "Senores Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating by MarketsMOJO as of 27 March 2026, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The company’s robust quarterly performance, market-beating returns, and evolving technical outlook have collectively driven this positive reassessment." }, { "title": "Senores Pharmaceuticals Ltd Shows Technical Momentum Shift Amid Positive Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-ltd-shows-technical-momentum-shift-amid-positive-market-returns-3923494", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SenoresPharmace_technicaldot_3923494.png", "date": "2026-03-30 08:03:24", "description": "Senores Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and volume-based metrics, suggesting cautious optimism for investors in this small-cap pharmaceutical player." } ], "total": 195, "sid": "10039497", "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "06-Apr-2026", "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Certificate pursuant to Regulation 74(5) of SEBI (DP)Regulations2018 for quarter ended March 31 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Acquisition", "datetime": "03-Apr-2026", "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of SEBI (LODR) Regulations 2015", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "03-Apr-2026", "details": "Senores Pharmaceuticals Limited has informed the Exchange regarding Media Release", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

30 Mar: Upgrade to Buy on strong financials and technical shift

30 Mar: Technical momentum shifts to mildly bullish

1 Apr: Significant gap up opens trading (+5.28%)

2 Apr: Downgrade to Hold amid mixed technicals and valuation concerns

Read full news article

Senores Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Valuation Concerns

2026-04-02 08:38:19

Senores Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 1 April 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust financial performance and market-beating returns, the company’s technical outlook and valuation metrics have prompted a more cautious stance from analysts.

Read full news article

Senores Pharmaceuticals Ltd Opens 5.28% Higher in Sharp Gap Up, But Can the Technicals Support It?

2026-04-01 09:36:55

Read full news article

Senores Pharmaceuticals Upgraded to Buy on Strong Financials and Technical Shift

2026-03-30 08:12:25

Senores Pharmaceuticals Ltd has been upgraded from a Hold to a Buy rating by MarketsMOJO as of 27 March 2026, reflecting significant improvements across quality, valuation, financial trends, and technical indicators. The company’s robust quarterly performance, market-beating returns, and evolving technical outlook have collectively driven this positive reassessment.

Read full news article

Senores Pharmaceuticals Ltd Shows Technical Momentum Shift Amid Positive Market Returns

2026-03-30 08:03:24

Senores Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and volume-based metrics, suggesting cautious optimism for investors in this small-cap pharmaceutical player.

Read full news article